The three-dimensional structure of the BowmanBirk type proteinase inhibitor (PI-11) has been deter; mined by x-ray crystallography and refined at 2.6-A resolution. This protein is a specific inhibitor of trypsin. Two reactive site loops, one at each end of the PI-I1 molecule, are structurally similar to each other and to reactive-site loops of pancreatic secretory trypsin inhibitor (Bolognesi, M., Gatti, G., Menegatti, E., Guarneri, M., Marquart, M., Papamokos, E., and Recent studies from laboratory animal tests and other experiments have shown that proteinase inhibitors of certain types are anticarcinogenic (3-5). The anticarcinogenic properties include the ability to reduce the forming of oxygen radicals (6, 7), to suppress the growth of chemical-induced colon and anal gland tumors (8, 9), breast tumor in rat (lo), and lung tumor in mice (ll), to suppress the radiation-induced elevation of c-myc mRNA (12, 13), to suppress the chemicalor radiation-induced cell transformation (14-16), to reduce spontaneous chromosome abnormality (17) (18) (19) , and to prevent tumor invasion and metastasis (20). The Bowman-Birk proteinase inhibitors (BBPIs)' (21) from soybeans or other plants are particularly interesting because these inhibitors are relatively stable at cooking temperature (21) and toward the acids found in the digestive system in humans and animals (5). Human populations which are known to have high concentrations of BBPI in their diet have lower rates of colon, breast, prostate, and skin cancers (22, 23) .
have molecular weights ranging from 7000 to 8000, and all contain seven disulfide bridges. The 14 half-cystine residues are conserved in all BBPIs and help to maintain their active conformation (24) . All BBPI molecules have two regions of tandem homology; each has a reactive site. Thus, BBPIs can inhibit two proteinases simultaneously and independently and are considered as "double-headed" inhibitors. Five closely related BBPIs have been isolated and characterized (25) from Tracy soybean seeds. These inhibitors are called PI-I through PI-V. The inhibitor PI-11, which is identical to that of inhibitor E-I reported by Odani and Ikenaka (26) , has 66 residues with a molecular mass of 7664 daltons. The amino acid residues around the reactive site of an inhibitor are usually designated (27) as P5, Plr P3, Pt, P1, P1', P2', P3', P4', P5', where PI-P1' is a reactive site peptide bond. The nature of PI generally is related to the substrate specificity of proteinase inhibited. The reactive site residue for elastase, for example, is alanine, that for trypsin is lysine or arginine, and that for chymotrypsin is leucine or phenylalanine (28). For most BBPIs these two P1 residues in the two homologous regions are different, but for PI-I1 they are both arginines (residues 15 and 41).
Crystallographic analyses of the Bowman-Birk proteinase family have not yet yielded a refined structure at high resolution. Suzuki et a1 (29) previously reported the unrefined structure of peanut (A-11) BBPI at 3.3-A resolution which appears to be similar to PI-11. In addition, the preliminary crystallographic data of a ternary complex consisting of achymotrypsin, @-trypsin, and BBPI has been reported (30) but the crystal structure is not yet available. The structure of PI-I1 has been determined by x-ray crystallography and refined at 2.5 A. As an inhibitor of serine proteinase, this structure will provide the first view of a refined double-headed enzyme inhibitor.
EXPERIMENTAL PROCEDURES
PI-I1 samples were isolated, purified, and crystallized as described by Wei (31) with some modifications. In a typical crystallization setup, approximately 1.6 mg of the lyophilized sample was dissolved in 150 pl of 0.2 M sodium acetate-acetic acid buffer at pH 4.6. A droplet containing 30 pl of the protein solution, 10 pl of a 1% sodium chloride solution, 5 pl of a 20% (w/v) polyethyleneglycol 4000 solution, 5 pl of a 1% sodium azide solution, and 5 pl of a saturated ammonium sulfate solution was placed on a microscope slide and sealed in a plastic sandwich box containing a reservoir of 40% saturated ammonium sulfate. The box was maintained at a constant temperature of 18 "C. After 3 days small crystals appeared and grew to a usable size (0.4-0.7 mm) in about 2 weeks.
The Diffraction data were collected on a Siemens area detector (32) using 10 kW graphite monochromatized CuK, x-ray-radiation. Native data (1186 0.2" data frames) from infinity to 2.3-A resolution were collected using two crystals with a crystal-to-detector distance of 14 cm and a swing angle (20) of 18.5". The exposure time was 200 s/ frame. The raw data (95.10% complete) were indexed, integrated, and scaled using XENGEN V1.3 (33). The R S~~, , , ( I ) based on 75,913 observations of the 5488 possible reflections to 2.28-A resolution was 7.77%. The Pt-derivative data set (infinity to 3-A resolution, 79.3% complete) was collected from a single crystal and consisted of 750 data frames (0.25") each exposed for 150 s. The data were processed as described above; after scaling, the Rsyrnm(1) based on 5869 observations of 2799 unique reflections was 5.46%.
The major Pt binding site was located by the Patterson search program HASSP (34) using SIR data to 3.0-A resolution and refined [600 centrosymmetric reflections; (Okl), (hOl), (hhl) , (hkk), and (hhh) zones] by the least-squares program SHELX76 (35). Difference Fourier maps were then used to locate three additional minor sites. After inclusion of the minor sites, the refinement converged to an R value of 0.494. The refined heavy atom parameters are given in Table I .
The space group ambiguity (P4132 us. P4,32) was resolved using the ISIR-ISAS program (36). For this analysis, anomalous scattering data to 5-A resolution were collected on a Rigaku AFC5R diffractometer. Next, 250 strong (peak to background ratio of 8 1 ) reflections having the largest Bijvoet differences were selected and the ISIR-ISAS process was then carried out twice, once in space group P4132
with heavy atoms at their refined locations (+++), and once in space group P4332 with heavy atoms at their inverted locations (---).
The statistics indicate that P&32 is most likely the correct space group, since it gives a higher figure-of-merit (0.70 us. 0.68), a larger correlation coefficient (0.89 us. 0.88) and a lower R value (0.38 us. 0.40) for an identical treatment by the program. The successful fitting of the left-handed residues into the electron density confirms the correct selection of the space group and the handedness of the heavy atom sites.
A number of electron density maps were then calculated using data with different resolution cutoffs in order to see which map would contain the most structural information. A map calculated using derivative data to 4.0 A followed by phase extension to 3.0 A gave the best chain connectivity, permitting a complete tracing of the polypeptide backbone and the initial identification of many side chains. This would suggest that the Pt derivative may be nonisomorphous beyond The initial molecular model was built on an Evans and Sutherland PS300 color graphics system with the program FRODO (37,38). The refinement was carried out by both stereochemically restrained leastsquares (39) and by simulated annealing (40). The chemical sequence of PI-I1 has been determined only for the first 20 residues (41), with the remaining residues being assumed (41) identical with those of the homologous inhibitor D-I1 isolated by Odani and Ikenada (26). Our electron density map agrees well with this suggested sequence except for residues between the two conserved half-cystines 23 and 31. Our results show that the sequence for residues 26 and 27 may be Arg26-Ilez7 instead of IleZ6-Arg7 (41). In addition, we found only 6 residues in this region instead of 7 residues found in D-11, thus Leuz8 in the suggested sequence (41) should be deleted since a comparison of primary sequences (24) of legume Bowman-Birk inhibitors shows that the number of amino acid residues can vary from six to eight between this pair of conserved half-cystines. Thus the modified (crystallographic) sequence is Cysz3-G1~24-Asp25-Arg26_Ilez7-Asn~-SerZ9-Cys3', and the further description of the structure in the text refers to this new sequence.
During the refinement, the resolution was extended from 3.0 to 2.5 
RESULTS AND DISCUSSION
The PI-I1 molecule resembles a "bow tie" (Figs. 1 and 2) with overall dimensions of approximately 45 X 24 X 20 A. It consists of a terminal "knot" and two homologous regions. The N-terminal residues, 3 to 7, and C-terminal residues, 60 to 63, are extended chains. The chains cross each other perpendicularly around residues 7 and 58 and are held together by a disulfide bridgt, Cys7-CysGo, and two hydrogFn bonds, 0 L y~~~-N C y s ' (2.88 A) and ODIAspg-NCysGo (2.76 A). is located near the tip of the outermost loop (Fig. 1) . The combination of seven disulfides, @-strand structure, and numerous intramolecular hydrogen bonds (described below) appears to be responsible for the extreme stability of the inhibitor under a variety of conditions such as boiling temperatures and strong acids (21).
A conserved feature of all BBPIs is the presence of seven disulfides. The disulfide linking pattern is in agreement with that deduced early by chemical methods (24). The C terminus is covalently linked to the N-terminal section of the molecule with Cys7-CysGo. Disulfide bridges in domain 1 are those between cystines 30-37, 34-49, 39-47, and in domain 2 are those between cystines 11-56,8-23, and 13-21 (Fig, 2) . These disulfide bridges provide high rigidity to the PI-I1 structure and may account for the observation that proteolytic cleavage of the two reactive sites causes a conformational change of only the loops containing the reactive sites; while the other portions are conformationally unchanged (42).
There are 31 intramolecular hydrogen boyds in PI-I1 with an average hydrogen bond length of 2.96 A; 18 are mainchain/main-chain bonds, nine are main-chain/side-chain bonds, and four are side-chain/side-chain bonds. Six of the 18 main-chain/main-chain hydrogen bonds are not involved in the @-structure. These numerous hydrogen bonds (compared to the molecular size) provide additional stability to the structure in addition to the seven disulfide bridges. For example, the hydrogen bonds AspZ5-Arg4', A~p~l -L y s~~, and A~p'l-Ser~~ provide the interactions stabilizing the connective peptide chains which link the two domains. Asps1 is invariant among all BBPIs, and Aspz5 is highly conserved. Besides contributing to the overall structural stability, Asp5' may be also important for the formation of disulfide bridge C Y S~~-Cys4' in initial folding; since the @-sheet terminates at residue 50, the formation of hydrogen bonds between Asp51 and Lys3' and S e P may be needed to bring Cys4' close to Cys34 (Fig. 2) . These observations are consistent with previous experiments (24,43) which show that each domain loses its stability and some of ita inhibitory activity when the connective chains are removed, and the decrease of inhibitory activity is greater for domain 2 than for domain 1.
From the PI-I1 structure we observed that each reactive site loop forms the same number of intramolecular hydrogen bonds. The highly conserved residues play the role of fuing the conformation of the reactive site loop. It has been shown that during enzyme inhibitor interaction only a small conformational adaptation of the inhibitor takes place (1). Thus structural rigidity is a major aspect of inhibitory function. Since both PI residues of PI-I1 are arginine, and it is doubleheaded exclusively for trypsin, a comparison of the two reactive site loops was carried out. In Fig. 3a, almost identical despite a difference of two amino acids.
We next compared the PI-I1 structure to the highly refiied structures of pancreatic secretory trypsin inhibitor (PSTI, the Kazal family) (1) and bovine pancreatic trypsin inhibitor (BPTI, the Kunitz family) (2). The only major common structural feature is the conformation of the reactive site loops; these loops project out from the inhibitors, so that they are accessible to the active sites of proteolytic enzymes. The "cores" of the inhibitors are quite different structurally despite a high disulfide content within each. In Fig. 3b , the reactive site P3-Ps' of PI-I1 and P3-P3' of PSTI are superimposed by a least-squares fitting of their C,s. Notice that the conformations of residues P3 through Pz' are extremely similar. All the carbonyl groups, and C@ atoms, are pointed in the same direction. In Fig. 3c , the reactive site of PI-I1 and BPTI are superimposed. Again, the conformations of residues Pp through Pz' are extremely similar. These similarities are also found in the comparison of Erthrinu trypsin inhibitor (the Kunitz type) (44) with PSTI.
Refined Crystal Structure of
Based on this striking similarity in reactive loops, and the fact that PSTI and BPTI do not change conformation upon binding enzyme (I), we expect the interaction between PI-I1 and trypsin to be very similar to that observed in the crystal structures of PSTI and BPTI complexes. The only significant difference would be that PI-I1 can bind two trypsin molecules simultaneously, while PSTI or BPTI binds only one trypsin molecule. For PI-I1 that binding is expected through the formation of salt-bridges between residues Arg" and Ar$' of PI-I1 and AsplS9 in the trypsin's specificity pocket. Since most residues on the P,' side of PI-I1 are in the interior of the inhibitor, the hydrogen bonding between PI-I1 and trypsin most likely involves Ps through Pz'. Furthermore, by considering the steric hindrance when two trypsins bind simultaneously, the contact region between PI-I1 and the enzymes probably includes only the outermost residues of reactive loops.
In summary, there are two prominent features in the structure of PI-11, as well as other proteinase inhibitors. One is the conformation of the reactive site loop which is complementary to the active site of the enzyme inhibited. This conformation allows inhibitors to bind to enzymes very tightly. Another is the structural rigidity which is attributed to an unusual number of disulfide bridges, hydrogen bonding, and extensive secondary structure. Upon enzyme inhibitor interaction the inhibitors are cleaved very slowly, if at all. If cleavage takes place, the conformational changes occur only locally around the cleaved bond due to the structural rigidity of the inhibitor molecule, while the remainder of the molecule stays intact.
